Bharat Biotech’s first intranasal Covid-19 Vaccine gets DCGI Approval
Tuesday saw the DCGI approve Bharat Biotech's first intranasal Covid-19 vaccine for primary vaccination against the virus for those over the age of 18. Health Minister Dr. Mansukh Mandaviya praised the accomplishment, calling it a "Big Boost to India's Fight Against COVID-19."
Mandaviya tweeted, "Big Boost to India's Fight Against COVID-19! Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation." Adding again that "This step will further strengthen our collective fight against the pandemic. India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM@NarendraModi Ji's lead...